Leptin, resistin, and hormonal and metabolic parameters in women with type 2 diabetes and in those with its concurrence with asthma


Cite item

Full Text

Abstract

Aim. To investigate the relationship between resistin, adiponectin, leptin, and hormonal and metabolic parameters in patients with type 2 diabetes mellitus (T2DM) and in those with its concurrence with asthma. Subjects and methods. Twenty-seven patients with T2DM and 26 patients with T2DM concurrent with asthma were examined. The examination data of 23 apparently healthy women served as a control. Anthropometric measurements, carbohydrate and lipid metabolic parameters, and leptin, resistin, adiponectin, interleukin (IL)-6 and IL-10 levels were studied. Results. Hyperleptinemia, hyperresistinemia, and lower adiponectin concentrations were found in the patients with T2DM and in those with its concurrence with asthma. These changes in the patients from these groups occurred in the presence of subclinical inflammation. Obvious insulin resistance (IR) accompanied by compensatory hyperinsulinemia was identified in the examined women. The detected atherogenic dyslipidemia appeared as increases in the levels of total cholesterol (C), triglycerides, low-density lipoprotein C, and atherogenic index and as a decrease in those of high-density lipoprotein C. The women with the concurrence of the diseases showed a positive correlation of the level of resistin with insulin and the HOMA index. Conclusion. The patients with T2DM and those with its concurrence with asthma exhibited obvious IR accompanied by compensatory hyperinsulinemia. Hyperresistinemia plays a role in the development of IR in the concurrence of these diseases. The patients with T2DM and those with its concurrence with asthma were found to have hyperleptinemia, hyperresistinemia, and a trend for decreasing adiponectin values in the presence of subclinical inflammation.

References

  1. Любавина H.A., Варварина Г.Н., Макарова Е.В., Меньков Н.В., Беляева Е.В., Ермолина Г.Б. Влияние нарушений углеводного обмена на микробиоценоз нижних дыхательных путей у больных с сочетанием бронхиальной астмы и сахарного диабета 2-го типа. Медицинский альманах. 2011;5(18):167-169. (Ljubavina N, Varvarina G, Makarova E, Men’kov N, Beljaeva E, Ermolina G. Vlijanie narushenij uglevodnogo obmena na mikrobiocenoz nizhnih dyhatel’nyh putej u bol’nyh s sochetaniem bronhial’noj astmy i saharnogo diabeta 2 tipa. Medicinskij al’manah. 2011;5(18):167-169.)
  2. Титова Е.А. Сахарный диабет и болезни органов дыхания / Е. А. Титова. Пульмонология. 2003;3:101-104. (Titova E. Saharnyj diabet i bolezni organov dyhanija. Pul’monologija. 2003;3:101-104.).
  3. Аметов А.С., Парнес Е.А., Черникова Н.А., Ермакова Е.А. Сердечно-сосудистые риски при сахарном диабете. Эндокринология. Новости. Мнения. Обучение. 2013;2:17-26. (Ametov A, Parnes E, Chernikova N, Ermakova E. Serdechno-sosudistye riski pri saharnom diabete. Jendokrinologija. Novosti. Mnenija. Obuchenie. 2013;2:17-26.
  4. Аметов А.С., Черникова Н.А., Ермакова Е. Сердечно-сосудистая безопасность интенсификации сахароснижающей терапии. Эндокринология. Новости. Мнения. Обучение. 2013;36:21-27. (Ametov A, Chernikova N, Ermakova E. Serdechno-sosudistaja bezopasnost’ intensifikacii saharosnizhajushhej terapii. Jendokrinologija. Novosti. Mnenija. Obuchenie. 2013;36:21-27.).
  5. Wenzel S. Mechanisms of severe asthma. Clin Exp Allergy. 2003;33(12):1622-1628.
  6. Бутрова С.А. Синдром инсулинорезистентности при абдоминальном ожирении. Лечащий врач. 1999;7:32-36. (Butrova S. Sindrom insulinorezistentnosti pri abdominal’nom ozhirenii. Lechashhij vrach. 1999;7:32-36.).
  7. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Издание 6. М.; 2013:118. (Dedov I, Shestakova M. Algoritmy specializirovannoj medicinskoj pomoshhi bol’nym saharnym diabetom. Izdanie 6. Moskva; 2013:118.).
  8. Глобальная стратегия лечения и профилактики бронхиальной астмы (пересмотр 2011 г.). Под ред. Белевского А.С. М.: Российское респираторное общество; 2012:108. (Global’naja strategija lechenija i profilaktiki bronhial’noj astmy (peresmotr 2011 g.). Pod red. Belevskogo A. Moskva: Rossijskoe respiratornoe obshhestvo; 2012:108.).
  9. Симбирцев А.С. Цитокины: классификация и биологические функции. Цитокины и воспаление. 2004;3(2):16-23. (Simbircev A. Citokiny: klassifikacija i biologicheskie funkcii. Citokiny i vospalenie. 2004;3(2):16-23.
  10. Соломонова Е., Вербовой А. Жировая ткань и адипокины. Saarbriicken: LAP LAMBERT Academic Publi-shing; 2012:115. (Solomonova E, Verbovoj A. Zhirovaja tkan’ i adipokiny. LAP LAMBERT Academic Publi-shing; 2012:115.).
  11. Шварц В. Жировая ткань как эндокринный орган. Проблемы эндокринологии. 2009;55(1):38-44. (Shvarc V. Zhirovaja tkan’ kak jendokrinnyj organ. Problemy jendokrinologii 2009;55(1):38-44.
  12. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in Agouti obese mice. Hypertension. 2002;39:486-490.

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies